PMV Pharmaceuticals Statistics

Total Valuation

PMVP has a market cap or net worth of $86.94 million. The enterprise value is -$97.51 million.

Market Cap	86.94M
Enterprise Value	-97.51M

Important Dates

The next estimated earnings date is Wednesday, August 7, 2024, before market open.

Earnings Date	Aug 7, 2024
Ex-Dividend Date	n/a

Share Statistics

PMVP has 51.44 million shares outstanding. The number of shares has increased by 12.39% in one year.

Shares Outstanding	51.44M
Shares Change (YoY)	+12.39%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	2.61%
Owned by Institutions (%)	92.60%
Float	40.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.41
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.79, with a Debt / Equity ratio of 0.06.

Current Ratio	16.79
Quick Ratio	n/a
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.10% and return on invested capital (ROIC) is -34.06%.

Return on Equity (ROE)	-29.10%
Return on Assets (ROA)	-26.20%
Return on Capital (ROIC)	-34.06%
Revenue Per Employee	n/a
Profits Per Employee	-$1.03M
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, PMVP has paid $3,000 in taxes.

Income Tax	3,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.20% in the last 52 weeks. The beta is 1.52, so PMVP's price volatility has been higher than the market average.

Beta (5Y)	1.52
52-Week Price Change	-74.20%
50-Day Moving Average	1.73
200-Day Moving Average	1.94
Relative Strength Index (RSI)	56.70
Average Volume (20 Days)	548,982

Short Selling Information

The latest short interest is 1.16 million, so 2.26% of the outstanding shares have been sold short.

Short Interest	1.16M
Short Previous Month	2.24M
Short % of Shares Out	2.26%
Short % of Float	2.87%
Short Ratio (days to cover)	1.94

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-76.87M
Pretax Income	-65.10M
Net Income	-65.10M
EBITDA	-64.02M
EBIT	-65.10M
Earnings Per Share (EPS)	-$1.33

Full Income Statement

Balance Sheet

The company has $198.76 million in cash and $13.02 million in debt, giving a net cash position of $185.74 million or $3.61 per share.

Cash & Cash Equivalents	198.76M
Total Debt	13.02M
Net Cash	185.74M
Net Cash Per Share	$3.61
Equity (Book Value)	212.68M
Book Value Per Share	4.13
Working Capital	190.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$56.83 million and capital expenditures -$1.40 million, giving a free cash flow of -$58.23 million.

Operating Cash Flow	-56.83M
Capital Expenditures	-1.40M
Free Cash Flow	-58.23M
FCF Per Share	-$1.13

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PMVP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.39%
Shareholder Yield	-12.39%
Earnings Yield	-73.79%
FCF Yield	-66.00%

Analyst Forecast

The average price target for PMVP is $5.75, which is 240.24% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.75
Price Target Difference	240.24%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-9.44%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2